Photodynamic therapy for subfoveal and juxtafoveal choroidal neovascularization associated with punctate inner choroidopathy

Ocular Immunology and Inflammation

Volumn 15, Issue 1, 2007, Pages 27-29

  Coco, Rosa M ^a   De Souza, Clairton Feitosa ^a   Sanabria, M Rosa ^a,b  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

Author keywords

Choroidal neovascularization (CNV); Photodynamic therapy (PDT); Punctate inner choroidopathy (PIC); Verteporfin

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ADULT; ARTICLE; CHOROID DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; PHOTODYNAMIC THERAPY; PUNCTATE INNER CHOROIDOPATHY; RECURRENT DISEASE; SUBRETINAL NEOVASCULARIZATION;

ADULT; CHOROIDAL NEOVASCULARIZATION; CHOROIDITIS; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FOVEA CENTRALIS; FUNDUS OCULI; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 33847315033     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940601174020     Document Type: Article

References (12)

1. Watzke RC, Packer AJ, Folk JC, Benson WE, Burgess D, Ober RR. Punctate inner choroidopathy. Am J Ophthalmol. 1984;98:572-584.
2. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One year results of two randomized clinical trials-Tap report 1. Arch Ophthalmol. 1999;117:1329-1345.
3. Verteporfin in photodynamic Therapy (VIP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial - VIP report no. 1. Ophthalmology. 2001;108:841-852.
4. Ciulla TA, Piper HC, Xiao M, Wheat LJ. Presumed ocular histoplasmosis syndrome: update on epidemiology, pathogenesis, and photodynamic, antiangiogenic, and surgical therapies. Curr Opin Ophthalmol. 2001;12:442-449.
5. Spaide RF, Freund KB, Slakter J, Sorenson J, Yanuzzi LA, Fisher Y. Treatment of subfoveal choroidal neovascularization associated with multifocal choroiditis and panuveitis with photodynamic therapy. Retina. 2002;22:545-549.
6. Wachtlin J, Heimann H, Behme T, Foerster MH. Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases. Graefes Arch Clin Exp Ophthalmol. 2003;241:899-906.
7. Leslie T, Lois N, Christopoulou D, Olson JA, Forrester JV. Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression. Br J Ophthalmol. 2005;89:147-150.
8. Park CL, Raizman MB. Punctate Inner Choroidopathy. In: Foster CS, Vitale A (eds.). Diagnosis and treatment of uveitis. W.B. Saunders: Philadelphia; 2002. pp. 806-812.
9. Brueggeman RM, Noffke AS, Jampol LM. Resolution of punctate inner choroidopathy lesions with oral prednisone therapy. Arch Ophthalmol. 2002;120:996.
10. Olsen TW, Capone A Jr, Sternbert P Jr., Grossniklaus HE, Martin DF, Aaberg TM. Subfoveal choroidal neovascularization in punctate inner choroidopathy. Surgical management and pathologic findings. Ophthalmology. 1996;103:2061-2069.
11. Macular Photocoagulation Study Group. Argon laser photocoagulation for ocular histoplasmosis. Results of a randomized clinical trial. Arch Ophthalmol. 1983;101:1347-1357.
12. Brancato R, Pece A, Avanza P, Radrizzani E. Photocoagulation scar expansion after laser therapy for choroidal neovascularization in degenerative miopía. Retina. 1990;10:239-243.